






The discovery and analysis of microRNAs (miRNAs) 
has revealed a new mechanism of gene regulation. 
miRNAs can base-pair with specific mRNA targets and 
regulate their expression at the post-transcriptional level 
[1]. Changes in miRNA abundance are implicated in 
controlling many biological processes including cellular 
senescence [2], an irreversible form of growth arrest 
involved in cellular aging.  The p53 and retinoblastoma 
(Rb) tumor suppressor pathways are essential for the 
establishment and maintenance of growth arrest during 
senescence [3], reflecting the need of cells to bypass 
senescence during carcinogenesis. 
 
Multiple miRNAs have been implicated in regulating 
the p53 pathway during cellular senescence. For 
example, miR-217 and the miR-34 family target the 
SIRT1 deacetylase gene. Reduction of SIRT1 expression 
by these miRNAs permits the maintenance of p53 
acetylation, resulting in p53 stabilization and the 
induction of senescence [4, 5].  In mouse embryonic 
fibroblasts, miR-20a represses the expression of the 
transcriptional regulator LRF (Leukemia/Lymphoma 
Related Factor), a repressor of the p19ARF gene. The 
absence of LRF increases the expression of p19ARF, 
which in turn inhibits the expression of the ubiquitin 
ligase MDM2, causing up-regulation of p53 and 
induction of senescence [6].  
 
Our group determined which miRNAs were 
differentially expressed during Rb-induced senescence, 
and we explored the roles of some of these miRNAs in 
this process [7].  We analyzed the global expression of 
miRNAs in an established model of cellular senescence 





















oncogene causes the rapid induction of Rb-dependent 
senescence in HeLa cervical carcinoma cells [8,9].  We 
found that 25 miRNAs were up-regulated and 24 were 
down-regulated in an Rb-dependent manner during 
induced senescence.  
 
Notably, several members of the miR-29 and miR-30 
families were up-regulated during senescence, and this 
up-regulation required activation of the Rb pathway. 
Further analysis showed that miR-29 and miR-30 target 
the 3’ untranslated region (3’UTR) of B-Myb mRNA 
[7]. The B-Myb oncogene (also known as MYBL2) 
encodes a transcription factor that regulates genes 
involved in control of the cell cycle, and modulation of 
B-Myb expression is known to influence senescence 
[10,11,12]. The interaction of miR-29 and miR-30 with 
the B-Myb 3’UTR inhibits gene expression during both 
induced and replicative senescence.  B-Myb expression 
can also be repressed by direct binding of Rb-E2F 
factors to the B-Myb promoter. Interestingly, over-
expression of miR-29 and miR-30 in proliferating cells 
suppresses  B-Myb expression and cellular DNA 
synthesis, and inhibiting the expression of these 
miRNAs allowed a population of cells to escape growth 
arrest caused by HPV E7 repression [7]. Based on these 
results, we concluded that miR-29 and miR-30 play an 
important role during Rb-induced senescence.  
 
miR-29 and miR-30 were previously implicated as 
potential tumor suppressor factors. For example, miR-
29 can inhibit DNA methylation in lung cancer cells by 
targeting DNA methyl-transferase 3A and 3B 
expression and suppress the growth of these cells [13].  
miR-29   can   also   repress   expression   of   the  T-cell  
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tumor suppressor in chronic lymphocytic leukemia [14].  
In addition, miR-29 was recently shown to repress 
expression of cdc42 and the p85 subunit of PI-3’ kinase, 
which in turns results in the stabilization of p53 and 
apoptosis [15].  miR-29 expression can also induce 
apoptosis in cholangiocarcinoma cells by down-
regulating expression of the anti-apoptotic protein Mcl-1 
[16].  Finally, a recent study showed that exogenous 
expression of miR-29a in lung and pancreatic cancer cell 
lines reduced proliferation and invasiveness in vitro. This 
group also used proteomics analysis to identify around 
100 differentially-expressed proteins as potential targets 
of miR-29a [17]. miR-30 expression is down-regulated in 
human breast, head-and-neck, and lung cancer in 
comparison to normal tissue, and transfection of miR-30 
decreased cell proliferation by targeting Ubc9, an enzyme 
involved in sumoylation [18]. Our finding that miR-29 
and miR-30 inhibit B-Myb expression suggests that B-
Myb repression may also contribute to the tumor 
suppressor activities of these miRNAs. 
 
We also investigated miRNA expression during 
replicative senescence in primary cells, a process that 
involves p53 as well as Rb.  Twenty-two miRNAs were 
affected during both replicative senescence in primary 
human foreskin fibroblasts and Rb-induced senescence in 
HeLa cells.  Remarkably, 20 of these 22 miRNAs 
(including some miR-29 and miR-30 family members) 
were regulated in the same direction in both types of 
senescence, whereas the abundance of only two miRNAs 
changed opposite directions, suggesting that the core 
Rb/miRNA circuit plays a similar role in induced and 
replicative senescence. In addition, a number of miRNAs 
were found to be induced or repressed during replicative 
senescence but not during Rb-induced senescence, 
suggesting that they may be targets of p53-mediated 
regulation.   
 
These findings raise a number of interesting questions. 
Are additional miRNAs involved in controlling 
irreversible growth arrest in replicative and induced 
senescence?  Do the same miRNAs regulate induced and 
replicative senescence?  Do different miRNAs regulate 
senescence in different tissues and cell types? Most 
importantly, which genes are targeted by these miRNAs 
and how do the products of these genes contribute to 
senescence? Further studies are likely to answer these 
questions and clarify the role of miRNAs in irreversible 
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